Data / Form D filings / Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc.: Form D filings
Venatorx Pharmaceuticals, Inc., a pharmaceuticals company in Malvern, PA, filed 8 Form D notices with the SEC between 2013 and 2023. The latest, on July 13, 2023, reports $35 million sold of a $48.2 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 30 SPRING MILL DRIVE, Malvern, PA, 19355
- Phone
- (610) 644-8935
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1590501
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | Amendment | $48,246,230 | $35,008,357 | $13,237,873 | 3 | Feb 17, 2023 | sec.gov |
| Feb 27, 2023 | New notice | $16,350,000 | $15,000,000 | $1,350,000 | 2 | Feb 17, 2023 | sec.gov |
| Dec 22, 2022 | Amendment | $24,700,001 | $24,700,001 | 2 | Aug 19, 2022 | sec.gov | |
| Sep 2, 2022 | New notice | $24,466,240 | $12,700,002 | $11,766,238 | 2 | Aug 19, 2022 | sec.gov |
| Apr 4, 2022 | New notice | $59,999,999 | $34,000,000 | $25,999,999 | 3 | Mar 18, 2022 | sec.gov |
| Nov 5, 2018 | Amendment | $47,127,560 | $27,127,661 | $19,999,899 | 47 | Jul 13, 2017 | sec.gov |
| Jul 25, 2017 | New notice | $41,999,936 | $21,900,067 | $20,099,869 | 42 | Jul 13, 2017 | sec.gov |
| Dec 4, 2013 | New notice | $3,978,000 | $3,419,051 | $558,949 | 59 | Nov 22, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy J Haines | Director | |
| Tomas C Heyman | Director | |
| Christopher J Burns | Executive Officer, Director | |
| Daniel C Pevear | Executive Officer | |
| Anthony J Meehan | Executive Officer | |
| Sergei J Petukhov | Director | |
| Martin J Heidecker | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Venatorx Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.